The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science
- PMID: 36335802
- PMCID: PMC9641002
- DOI: 10.1016/j.neo.2022.100846
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science
Abstract
Pediatric brain tumors are the leading cause of cancer-related death in children in the United States and contribute a disproportionate number of potential years of life lost compared to adult cancers. Moreover, survivors frequently suffer long-term side effects, including secondary cancers. The Children's Brain Tumor Network (CBTN) is a multi-institutional international clinical research consortium created to advance therapeutic development through the collection and rapid distribution of biospecimens and data via open-science research platforms for real-time access and use by the global research community. The CBTN's 32 member institutions utilize a shared regulatory governance architecture at the Children's Hospital of Philadelphia to accelerate and maximize the use of biospecimens and data. As of August 2022, CBTN has enrolled over 4700 subjects, over 1500 parents, and collected over 65,000 biospecimen aliquots for research. Additionally, over 80 preclinical models have been developed from collected tumors. Multi-omic data for over 1000 tumors and germline material are currently available with data generation for > 5000 samples underway. To our knowledge, CBTN provides the largest open-access pediatric brain tumor multi-omic dataset annotated with longitudinal clinical and outcome data, imaging, associated biospecimens, child-parent genomic pedigrees, and in vivo and in vitro preclinical models. Empowered by NIH-supported platforms such as the Kids First Data Resource and the Childhood Cancer Data Initiative, the CBTN continues to expand the resources needed for scientists to accelerate translational impact for improved outcomes and quality of life for children with brain and spinal cord tumors.
Keywords: Biospecimens; Collaborative international research infrastructure; Longitudinal clinical data; Molecular clinical trials; Multi-omic data; Pediatric brain tumors.
Copyright © 2022. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. David S. Ziegler is a consultant, or on the advisory board, of Bayer, AstraZeneca, Accendatech, Novartis, Day One, FivePhusion, Amgen, Alexion, and Norgine. Angela J. Waanders is on the advisory board of Alexion and Day One.
Figures

Similar articles
-
OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom. 2023 May 31;3(7):100340. doi: 10.1016/j.xgen.2023.100340. eCollection 2023 Jul 12. Cell Genom. 2023. PMID: 37492101 Free PMC article.
-
Pioneering models of pediatric brain tumors.Neoplasia. 2023 Feb;36:100859. doi: 10.1016/j.neo.2022.100859. Epub 2023 Jan 3. Neoplasia. 2023. PMID: 36599191 Free PMC article.
-
Informatics Methods and Infrastructure Needed to Study Factors Associated with High Incidence of Pediatric Brain and Central Nervous System Tumors in Kentucky.J Registry Manag. 2020 Fall;47(3):127-134. J Registry Manag. 2020. PMID: 34128919 Free PMC article.
-
The Minderoo-Monaco Commission on Plastics and Human Health.Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
-
Pediatric biobanks to enhance clinical and translational research for children.Eur J Pediatr. 2023 Apr;182(4):1459-1468. doi: 10.1007/s00431-023-04818-3. Epub 2023 Jan 24. Eur J Pediatr. 2023. PMID: 36692622 Free PMC article. Review.
Cited by
-
MAJIQlopedia: an encyclopedia of RNA splicing variations in human tissues and cancer.Nucleic Acids Res. 2024 Jan 5;52(D1):D213-D221. doi: 10.1093/nar/gkad1043. Nucleic Acids Res. 2024. PMID: 37953365 Free PMC article.
-
Pediatric brain tumor classification using deep learning on MR images with age fusion.Neurooncol Adv. 2024 Dec 2;7(1):vdae205. doi: 10.1093/noajnl/vdae205. eCollection 2025 Jan-Dec. Neurooncol Adv. 2024. PMID: 39777258 Free PMC article.
-
Consistently processed RNA sequencing data from 50 sources enriched for pediatric data.Sci Data. 2025 Jul 2;12(1):1134. doi: 10.1038/s41597-025-05376-z. Sci Data. 2025. PMID: 40603900 Free PMC article.
-
Training and Comparison of nnU-Net and DeepMedic Methods for Autosegmentation of Pediatric Brain Tumors.AJNR Am J Neuroradiol. 2024 Aug 9;45(8):1081-1089. doi: 10.3174/ajnr.A8293. AJNR Am J Neuroradiol. 2024. PMID: 38724204 Free PMC article.
-
Novel mouse model reveals neurodevelopmental origin of PMM2-CDG brain pathology.bioRxiv [Preprint]. 2025 Jun 3:2025.06.01.657261. doi: 10.1101/2025.06.01.657261. bioRxiv. 2025. PMID: 40501776 Free PMC article. Preprint.
References
-
- Curtin SC, Minino AM, Anderson RN. Declines in Cancer Death Rates Among Children and Adolescents in the United States, 1999-2014. NCHS Data Brief. 2016;(257):1–8. - PubMed
-
- Pediatric brain tumor atlas [Internet]. [cited 2022 Oct 2]. Available from: https://cbtn.org/pediatric-brain-tumor-atlas
-
- Gabriella miller kids first [Internet]. 2021 [cited 2022 Oct 2]. Available from: https://commonfund.nih.gov/kidsfirst/2021X01projects
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials